Joshua Sterling, MD
Urology · New Haven, CTNPI 1477007722
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Boston Scientific at 49.2% of the total. Reporting peaked in 2019 at $1,357 and has fallen 72.8% since, to $369 in 2025.
Across 31 payments — averaging $93.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Intuitive Surgical$500
- Innovation Technologies Inc$363
- Medtronic$330
- Profound Medical Corp.$154
- Integra Lifesciences Corporation$55
- plus $68 from 2 others
Across 2 payments — averaging $4024.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Innovation Technologies Inc$8K
What the payments were for
- Speaking & faculty fees$50017%
- Travel & lodging$94933%
- Food & beverage$1,44550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $1,424 |
| Intuitive Surgical | 1 | $500 |
| Innovation Technologies Inc | 4 | $363 |
| Medtronic | 4 | $330 |
| Profound Medical Corp. | 1 | $154 |
| Integra Lifesciences Corporation | 2 | $55 |
| Coloplast | 2 | $38 |
| Ambu Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,894 in reported general payments places this provider in the 60th percentile of 156 urology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 31 | $31,472 |
| MyrbetriqMirabegron | 41 | $23,073 |
| Solifenacin Succinate | 36 | $962 |
| Methenamine Hippurate | 15 | $878 |
| Tamsulosin Hcl | 98 | $868 |
| Finasteride | 31 | $306 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $225 |
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $196 |
| Testosterone Cypionate | 15 | $128 |
| Triamcinolone Acetonide | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other urology in New Haven
- Daniel KellnerNew Haven$122K
- Preston SprenkleNew Haven$57K
- Stanton HonigNew Haven$40K
- Michael LeapmanNew Haven$21K
- Jason LeeNew Haven$19K
- Leslie RickeyNew Haven$17K
- Gregory LacyNew Haven$11K
- Fady GhaliNew Haven$10K
- Guy ManettiNew Haven$7K
- Wei Shen TanNew Haven$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.